期刊文献+

新型非典型抗精神病药临床应用评价 被引量:42

Evaluation of new atypical antipsychotics in clinical application
暂未订购
导出
摘要 目前非典型抗精神病药应用越来越广泛,有逐渐取代典型抗精神病药的趋势,不但用于精神分裂症的治疗,而且作为心境稳定剂治疗情感障碍。本文对非典型抗精神病药的概念、治疗阴性症状和较少锥体外系不良反应的机制、在精神分裂症和情感障碍治疗中的临床应用评价等文献进行综述,重点讨论奥氮平、利司哌酮、喹硫平、阿立哌唑、齐哌西酮、氨磺必利和哌罗匹隆。 Atypical antipsychotics(AAP) are utilized extensively now a days to treat not only schizophrenia but also for mood disorders as mood stabilizer because of the effect and the safety for positive and negative symptoms of schizophrenia and the affective symptoms of affective disorders especially bipolar disorders. A review of recent literatures concerned about the concept and application of AAP such as olanzapine,risperidone, quetiapine,aripiprazole,ziprasidone,amisulpiride and perospirone as well for schizophrenia and mood disorders are evaluated.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第4期296-301,共6页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家"十五"科技攻关项目(2004BA720A22)
关键词 奥氮平 利司哌酮 喹硫平 阿立哌唑 齐哌西酮 哌罗匹隆 氨磺必利 非典型抗精神病药 olanzapine risperidone quetiapine aripiprazole ziprasidone perospirone amisulpiride atypical antipsychotic
  • 相关文献

参考文献29

  • 1SERRETTI A,De RONCHI D,LORENZI C,et al.New antipsychotics and schizophrenia:a review on efficacy and side effects[J].Curr Med Chem,2004,11 (3):343-358.
  • 2DEAN B,SCARR E.Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits[J].Curr Drug Targets CNS Neurol Disord,2004,3(3):217-225.
  • 3HOULTRAM B,SCANLAN M.Care maps:atypical antipsychotics.Introduction[J].Nurs Stand,2004,18 (36):42-44.
  • 4VOLAVKA J,CZOBOR P,SHEITMAN B,et al.Clozapine,olanzapine,risperidone,and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder[J].Am J Psychiatry,2002,159 (2):255-262.
  • 5BITTER I,DOSSENBACH MR,BROOK S,et al.Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia[J].Prog Neuropsychopharmacol Biol Psychiatry,2004,28(1):173-180.
  • 6JESTE DV,BARAK Y,MADHUSOODANAN S,et al.International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia[J].Am J Geriatr Psychiatry,2003,11 (6):638-647.
  • 7MULLEN J,JIBSON MD,SWEITZER D.A comparison of the relative safety,efficacy,and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders:the quetiapine experience with safety and tolerability(QUEST) study[J].Clin Ther,2001,23(11):1839-1854.
  • 8ARGO TR,CARNAHAN RM,PERRY PJ.Aripiprazole,a novel atypical antipsychotic drug[J].Pharmacotherapy,2004,24 (2):212-228.
  • 9POTKIN SG,SAHA AR,KUJAWA MJ,et al.Aripiprazole,an antipsychotic with a novel mechanism of action,and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder[J].Arch Gen Psychiatry,2003,60(7):681-690.
  • 10KANE JM,CARSON WH,SAHA AR,et al.Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder[J].J Clin Psychiatry,2002,63(9):763-771.

二级参考文献26

  • 1KIKUCHI T,TOTTORI K, UWAHODO Y, et al. 7-(4-[4-(2,3-Dichlorophenyl) -1 -piperazinyl ] butyloxy ) -3, 4-dihydro-2 ( 1H ) -quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity [J]. J Pharmacol Exp Ther, 1995, 274( 1 ): 329-336.
  • 2McGAVIN JK, GOA KL. Aripiprazole [J]. CNS Drugs, 2002,16(11) :779-786.
  • 3SHAPIRO DA, RENOCK S, ARRINGTON E, et al. Aripiprazole,a novel atypical antipsychotic drug with a unique and robust pharmacology [ J ]. Neuropsychopharmacology, 2003, 28 (8): 1400-1411.
  • 4MARDER SR, McQUADE RD, STOCK E, et al. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term,placebo-controlled trials [ J ]. Schizophrt Res,2003,61 (2-3): 123-136.
  • 5KINGHORN WA, McEVOY JP. Aripiprazole: pharmacology, efficacy, safety and tolerability [ J]. Expert Rev Neurother, 2005, 5(3) :297-307.
  • 6Kazutoyo I, Shin I, Akinori U, et al. Phase I study of perospirone HCl(SM-9018). Clinical Report, 1997, 31(6) : 188
  • 7Mario N. Biotransformation of post-clozapine antipsychotics pharmacological implications. Clin Pharmacokinet, 2000, 38(5) : 393
  • 8Takahashi Y, Kusumi I, Ishikane T, et al. In vivo occupation of dopa mine D1, D2 and serotonin 2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain. J Neural Transm,1998, 105(2-3) : 181
  • 9Tanaka H, Ohno Y, Nakamure M. Localization and pharmacological characterization of [3H] perospirone-binding sites in rat brain.Gen Pharmcal, 1998, 31(1) : 159
  • 10Ishibashi T, Tagashira R, Nakamure M, et al. Effects of perospirone, a novel 5-HT2 and D2 receptor antagonist, on fos protein expression in the rat forebrain. Pharmacol biochem Behav, 1999,63(4) : 535

共引文献118

同被引文献372

引证文献42

二级引证文献380

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部